Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Cirrhosis | 4 | 2015 | 64 | 1.160 |
Why?
|
| HIV Infections | 6 | 2015 | 890 | 1.060 |
Why?
|
| Hepatitis C | 3 | 2015 | 67 | 1.010 |
Why?
|
| Ageusia | 1 | 2022 | 1 | 0.840 |
Why?
|
| Hepatitis C, Chronic | 2 | 2015 | 80 | 0.570 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2015 | 226 | 0.520 |
Why?
|
| Thromboplastin | 1 | 2015 | 7 | 0.500 |
Why?
|
| Interleukin-10 | 1 | 2013 | 39 | 0.450 |
Why?
|
| Herpes Zoster | 1 | 2013 | 5 | 0.450 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2013 | 178 | 0.430 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 217 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 191 | 0.380 |
Why?
|
| Coinfection | 4 | 2015 | 31 | 0.300 |
Why?
|
| Blastomycosis | 1 | 2005 | 17 | 0.260 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 1009 | 0.210 |
Why?
|
| Cough | 1 | 2022 | 12 | 0.210 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 17 | 0.210 |
Why?
|
| Antibody Formation | 1 | 2022 | 38 | 0.210 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 89 | 0.200 |
Why?
|
| RNA, Messenger | 1 | 2022 | 328 | 0.190 |
Why?
|
| Neurosyphilis | 1 | 2021 | 5 | 0.190 |
Why?
|
| Treponema pallidum | 1 | 2021 | 7 | 0.190 |
Why?
|
| Adult | 6 | 2015 | 8924 | 0.190 |
Why?
|
| Biomarkers | 2 | 2015 | 733 | 0.180 |
Why?
|
| Middle Aged | 6 | 2015 | 10192 | 0.180 |
Why?
|
| Humans | 9 | 2022 | 30959 | 0.160 |
Why?
|
| Viral Load | 3 | 2015 | 196 | 0.160 |
Why?
|
| HIV-1 | 2 | 2013 | 459 | 0.160 |
Why?
|
| Hepacivirus | 2 | 2015 | 76 | 0.150 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2015 | 10 | 0.150 |
Why?
|
| Female | 6 | 2015 | 16965 | 0.140 |
Why?
|
| Receptors, Immunologic | 1 | 2015 | 36 | 0.130 |
Why?
|
| Male | 4 | 2015 | 16425 | 0.120 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2015 | 145 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2015 | 112 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2015 | 204 | 0.120 |
Why?
|
| HLA-DR Antigens | 1 | 2013 | 27 | 0.110 |
Why?
|
| Herpes Zoster Vaccine | 1 | 2013 | 2 | 0.110 |
Why?
|
| Herpesvirus 3, Human | 1 | 2013 | 6 | 0.110 |
Why?
|
| Liver | 1 | 2015 | 184 | 0.110 |
Why?
|
| Health Care Surveys | 1 | 2013 | 68 | 0.110 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2013 | 131 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2015 | 271 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 155 | 0.100 |
Why?
|
| Life Style | 1 | 2013 | 226 | 0.100 |
Why?
|
| Genes, MHC Class I | 1 | 2010 | 5 | 0.090 |
Why?
|
| HLA-B Antigens | 1 | 2010 | 11 | 0.090 |
Why?
|
| Antigen Presentation | 1 | 2010 | 22 | 0.090 |
Why?
|
| Incidence | 1 | 2013 | 785 | 0.090 |
Why?
|
| Chicago | 1 | 2013 | 943 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 1210 | 0.080 |
Why?
|
| United States | 1 | 2013 | 2373 | 0.070 |
Why?
|
| Aged | 2 | 2013 | 10047 | 0.070 |
Why?
|
| Illinois | 1 | 2005 | 267 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2005 | 689 | 0.060 |
Why?
|
| Fluorescent Treponemal Antibody-Absorption Test | 1 | 2021 | 3 | 0.050 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2021 | 4 | 0.050 |
Why?
|
| Child | 1 | 2005 | 1428 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1133 | 0.050 |
Why?
|
| Point-of-Care Testing | 1 | 2021 | 32 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2015 | 1897 | 0.040 |
Why?
|
| Adolescent | 1 | 2005 | 2399 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 2042 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 5189 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2015 | 162 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 273 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 341 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2015 | 660 | 0.030 |
Why?
|
| HLA-A Antigens | 1 | 2010 | 13 | 0.020 |
Why?
|
| Amino Acids | 1 | 2010 | 22 | 0.020 |
Why?
|
| HIV Long-Term Survivors | 1 | 2010 | 10 | 0.020 |
Why?
|
| HLA-C Antigens | 1 | 2010 | 10 | 0.020 |
Why?
|
| HIV Antigens | 1 | 2010 | 23 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 70 | 0.020 |
Why?
|
| Haplotypes | 1 | 2010 | 61 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 84 | 0.020 |
Why?
|
| Alleles | 1 | 2010 | 227 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2010 | 97 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 409 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 309 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 314 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 830 | 0.020 |
Why?
|